Everolimus in combination with octreotide LAR in thymic atypical carcinoid

Abstract Thymic atypical carcinoids are extremely rare tumors and have a poor prognosis owing to their aggressive clinical course. The efficacy of treatments other than complete surgical resection is unclear. We herein report a postoperative recurrent case of thymic atypical carcinoid treated with e...

Full description

Bibliographic Details
Published in:Thoracic Cancer
Main Authors: Tadashi Sakane, Tomoharu Nakano, Emi Hagui, Hiroshi Haneda, Katsuhiro Okuda
Format: Article
Language:English
Published: Wiley 2023-05-01
Subjects:
atypical carcinoid
everolimus
octreotide
thymic carcinoid
Online Access:https://doi.org/10.1111/1759-7714.14887

Internet

https://doi.org/10.1111/1759-7714.14887

Similar Items